https://doctransparency.com/doctor/tx/dallas/thomas-lucas-1568411411
Medicare Enrolled

Dr. Thomas Lucas, MD

Psychiatry · Dallas, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
3500 OAKLAWN AVE, Dallas, TX 75219
9727091961
In practice since 2006 (19 years)
NPI: 1568411411 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lucas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lucas? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lucas

Dr. Thomas Lucas is a psychiatry in Dallas, TX, with 19 years in practice. Based on federal Medicare data, Dr. Lucas performed 2,204 Medicare services across 411 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lucas received a total of $53,087 from 46 pharmaceutical and/or device companies across 656 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lucas is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 3% volume in TX$ $53,087 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,204
Medicare services
Top 3% in TX for psychiatry
411
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~116 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or963$23$70
Office visit, established patient (30-39 min)506$89$137
Psychotherapy with evaluation and management visit, 30 minutes376$49$106
Office visit, established patient, complex (40-54 min)240$130$200
Psychotherapy with evaluation and management visit, 45 minutes59$67$125
Psychiatric services complicated by communication factor33$11$25
New patient office visit, complex (60-74 min)27$151$395
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$53,087
Total received (2018-2024)
Avg $7,584/year across 7 years
Top 3% in TX for psychiatry
46
Companies
656
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$38,203 (72.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,883 (28.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,211
2023
$2,813
2022
$1,857
2021
$4,345
2020
$2,335
2019
$6,112
2018
$33,414

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Avanir Pharmaceuticals, Inc.
$38,355
Validus Pharmaceuticals LLC
$3,861
Otsuka America Pharmaceutical, Inc.
$1,583
Neurocrine Biosciences, Inc.
$1,477
Lundbeck LLC
$909
Takeda Pharmaceuticals U.S.A., Inc.
$684
Janssen Pharmaceuticals, Inc
$646
Corium, LLC
$516
Alkermes, Inc.
$474
ABBVIE INC.
$429
ITI, Inc.
$381
Almatica Pharma LLC
$363
Supernus Pharmaceuticals, Inc.
$358
Neos Therapeutics, LP
$306
IDORSIA PHARMACEUTICALS US INC
$259
ACADIA Pharmaceuticals Inc
$220
Tris Pharma Inc
$208
Merck Sharp & Dohme Corporation
$179
Shire North American Group Inc
$172
Merck Sharp & Dohme LLC
$169
Eisai Inc.
$151
Allergan Inc.
$135
Vanda Pharmaceuticals Inc.
$133
JAZZ PHARMACEUTICALS INC.
$122
Teva Pharmaceuticals USA, Inc.
$97
Axsome Therapeutics, Inc.
$96
AbbVie Inc.
$94
Lilly USA, LLC
$86
Allergan, Inc.
$76
Noven Therapeutics, LLC
$74
Sunovion Pharmaceuticals Inc.
$69
Ironshore Pharmaceuticals Inc.
$50
Arbor Pharmaceuticals, Inc.
$48
ARBOR PHARMACEUTICALS, INC.
$47
HARMONY BIOSCIENCES LLC
$36
LivaNova USA, Inc.
$34
Novartis Pharmaceuticals Corporation
$26
OWP Pharmaceuticals, Inc.
$24
Azurity Pharmaceuticals, Inc.
$24
E.R. Squibb & Sons, L.L.C.
$23
Amgen Inc.
$19
Bausch Health US, LLC
$19
Adlon Therapeutics L.P.
$15
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$14
Aytu BioPharma, Inc.
$14
Aytu BioScience, Inc
$11
Top 3 companies account for 82.5% of total payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ADHANSIA XR · APLENZIN · ARISTADA · AZSTARYS · Adzenys XR-ODT · Aimovig · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · COBENFY · Dayvigo · Dyanavel XR · Equetro · Evekeo · FANAPT · Fanapt · Fycompa · GRALISE · Horizant · INGREZZA · INVEGA SUSTENNA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · KISUNLA · LATUDA · LOREEV XR · LYBALVI · Lamotrigine Starter Kit · MYDAYIS · NUEDEXTA · NUPLAZID · Natesto · Nuedexta · QELBREE · QUVIVIQ · Qelbree · REXULTI · SPRAVATO · SUNOSI · Secuado · Subvenite · TRINTELLIX · Trintellix · VNS THERAPY SYMMETRY MODEL 8103 GENERATOR · VNS Therapy · VRAYLAR · VYVANSE · WAKIX · Wakix · XYWAV
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (72%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in psychiatry and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for psychiatry in TX.

Equivalent to $2,409 per 100 Medicare services performed
Looking for a psychiatry in Dallas?
Compare psychiatrys in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse psychiatrys nearby

Geographic Context

Psychiatrys within 10 mi
564
Per 100K population
21.7
County median income
$74,149
Nearest hospital
TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Lucas is a clinical cardiology specialist, with above-average Medicare volume (top 3% in TX), and high industry engagement (speaking/promotional, top 3%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Lucas experienced with prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or?
Based on Medicare claims data, Dr. Lucas performed 963 prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lucas receive payments from pharmaceutical companies?
Yes. Dr. Lucas received a total of $53,087 from 46 companies across 656 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lucas's costs compare to other psychiatrys in Dallas?
Dr. Lucas's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lucas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →